Levodopa/carbidopa and entacapone in the treatment of Parkinson’s disease: efficacy, safety and patient preference
Thomas Müller1,21Department of Neurology, St. Joseph Hospital Berlin-Weißensee, Berlin, Germany; 2IGSN, Ruhr University of Bochum, Bochum, GermanyAbstract: Levodopa (LD) is the oldest, most efficacious and best-tolerated drug for dopaminergic substitution of patients with...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2009-01-01
|
| Series: | Patient Preference and Adherence |
| Online Access: | http://www.dovepress.com/levodopacarbidopa-and-entacapone-in-the-treatment-of-parkinsonrsquos-d-a2826 |